UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 314

Sortiert nach

Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts

British journal of cancer, 2013-02, Vol.108 (2), p.319-326

2013

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 (IL-6) as an Anti-inflammatory Cytokine: Induction of Circulating IL-1 Receptor Antagonist and Soluble Tumor Necrosis Factor Receptor p55

Blood, 1994-01, Vol.83 (1), p.113-118

1994

Link zum Volltext

Verfügbarkeit prüfen

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies

Clinical cancer research, 1997-03, Vol.3 (3), p.409-417

1997

Link zum Volltext

Verfügbarkeit prüfen

Antiinflammatory properties of hepatic acute phase proteins : preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells

The Journal of experimental medicine, 1993-11, Vol.178 (5), p.1629-1636

1993

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

Blood, 2001-11, Vol.98 (9), p.2720-2725

2001

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Journal of clinical oncology, 1993-04, Vol.11 (4), p.661-670

1993

Link zum Volltext

Verfügbarkeit prüfen

Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells

The Journal of biological chemistry, 2001-03, Vol.276 (10), p.6893-6896

2001

Link zum Volltext

Verfügbarkeit prüfen

Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth

The Journal of biological chemistry, 2000-01, Vol.275 (2), p.1209-1215

2000

Link zum Volltext

Verfügbarkeit prüfen

Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1052-1062

1997

Link zum Volltext

Verfügbarkeit prüfen

Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

The New England journal of medicine, 1988-06, Vol.318 (24), p.1557-1563

1988

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Twice-Weekly Intravenous Interleukin 12 in Patients with Metastatic Renal Cell Cancer or Malignant Melanoma: Ability to Maintain IFN-γ Induction Is Associated with Clinical Response

Clinical cancer research, 2000-05, Vol.6 (5), p.1678

2000

Link zum Volltext

Verfügbarkeit prüfen

Impairment of STAT Activation by IL-12 in a Patient with Atypical Mycobacterial and Staphylococcal Infections

The Journal of immunology (1950), 2000-10, Vol.165 (7), p.4120-4126

2000

Link zum Volltext

Verfügbarkeit prüfen

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

Annals of internal medicine, 1988-04, Vol.108 (4), p.518

1988

Link zum Volltext

Verfügbarkeit prüfen

Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans

The Journal of immunology (1950), 1993-08, Vol.151 (3), p.1637

1993

Link zum Volltext

Verfügbarkeit prüfen

Induction of circulating IL-1 receptor antagonist by IFN treatment

The Journal of immunology (1950), 1993-05, Vol.150 (10), p.4687

1993

Link zum Volltext

Verfügbarkeit prüfen

Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma

Journal of clinical oncology, 1994-08, Vol.12 (8), p.1553-1560

1994

Link zum Volltext

Verfügbarkeit prüfen

Calpain Regulates Actin Remodeling during Cell Spreading

The Journal of cell biology, 1998-05, Vol.141 (3), p.647-662

1998

Link zum Volltext

Verfügbarkeit prüfen

IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells

The Journal of immunology (1950), 1988-12, Vol.141 (12), p.4250

1988

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study

Journal of clinical oncology, 1991-10, Vol.9 (10), p.1821-1830

1991

Link zum Volltext

Verfügbarkeit prüfen

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy

Journal of clinical oncology, 1992-11, Vol.10 (11), p.1802-1809

1992

Link zum Volltext

Verfügbarkeit prüfen

An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 Immunotherapy

The New England journal of medicine, 1990-04, Vol.322 (14), p.959-965

1990

Link zum Volltext

Verfügbarkeit prüfen

Multiple biological activities of human recombinant interleukin 1

The Journal of clinical investigation, 1986-06, Vol.77 (6), p.1734-1739

1986

Link zum Volltext

Verfügbarkeit prüfen

Purification and Some Characteristics of Human T-Cell Growth Factor from Phytohemagglutinin-Stimulated Lymphocyte-Conditioned Media

Proceedings of the National Academy of Sciences - PNAS, 1980-10, Vol.77 (10), p.6134-6138

1980

Link zum Volltext

Verfügbarkeit prüfen

IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury

The Journal of immunology (1950), 1988-07, Vol.141 (1), p.158

1988

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6-associated anemia : determination of the underlying mechanism

Blood, 1995-08, Vol.86 (4), p.1288-1291

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 314

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(261)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Humans
(153)
Life Sciences & Biomedicine
(153)
Biological And Medical Sciences
(69)
Male
(68)
Female
(63)
Oncology
(59)
Adult
(53)
Medical Sciences
(51)
Middle Aged
(51)
Animals
(46)
Immunology
(39)
Aged
(36)
Mice
(30)
Pharmacology. Drug Treatments
(27)
Immunotherapy
(26)
Physical Sciences
(24)
Interleukin-2 - Adverse Effects
(23)
Antineoplastic Agents
(22)
Interleukin-2 - Administration & Dosage
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts

Interleukin-6 (IL-6) as an Anti-inflammatory Cytokine: Induction of Circulating IL-1 Receptor Antagonist and Soluble Tumor Necrosis Factor Receptor p55

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies

Antiinflammatory properties of hepatic acute phase proteins : preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells

Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth

Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma

Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

Phase I Trial of Twice-Weekly Intravenous Interleukin 12 in Patients with Metastatic Renal Cell Cancer or Malignant Melanoma: Ability to Maintain IFN-γ Induction Is Associated with Clinical Response

Impairment of STAT Activation by IL-12 in a Patient with Atypical Mycobacterial and Staphylococcal Infections

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans

Induction of circulating IL-1 receptor antagonist by IFN treatment

Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma

Calpain Regulates Actin Remodeling during Cell Spreading

IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells

Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy

An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 Immunotherapy

Multiple biological activities of human recombinant interleukin 1

Purification and Some Characteristics of Human T-Cell Growth Factor from Phytohemagglutinin-Stimulated Lymphocyte-Conditioned Media

IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury

Interleukin-6-associated anemia : determination of the underlying mechanism

Suchergebnisse filtern